Nobody is worried about trademark infringement because the only entity that can sue them -- Radient -- is DEAD and GONE.
But who is marketing the test as onko-sure or DR-70 other than UNI though? GCDx is not and CSTamdl is not. Is it just UNI?
Let's pretend, then, that UNI is licensing the name "Onko-Sure" and/or "DR-70" from AMDL Inc. If Arima or Pharmigene or anyone else ever gets around to selling the test, and they want to use the names Onko-Sure or DR-70, they can license that from AMDL.
Every time an entity uses these trademarked names, the case for the Resurrection of Radient Pharmaceuticals, and with it RXPC stock, gets WORSE. MacLellan and Ariura have no reason to resurrect Radient Pharmaceuticals if they can get the licensing fees through AMDL and keep all the money themselves.
